hotspot -WSS

hotspot

author：entertainment 2025-08-12 09:13:29 - browse：85851

Photo illustration with orange background of Desmond Padhi, PharmD, interim CEO, Latigo (center), with Latigo board chair Nancy Stagliano (left) and Westlake Village BioPartners founding managing director Sean Harper, M.D. (right) -- biotech coverage from STAT — Desmond Padhi, PharmD, interim CEO, Latigo (center), with Latigo board chair Nancy Stagliano (left) and Westlake Village BioPartners founding managing director Sean Harper, M.D. (right) Illustration: Christine Kao/STAT; Courtesy: Steve Shoffner & Michael Haber

After three years being incubated by California VC Westlake Village BioPartners, a new biotech launched Wednesday with $135 million and plans to compete with Vertex Pharmaceuticals.

The startup is called Latigo Biotherapeutics, and it’s launching having already started a Phase 1 trial for a non-opioid pain medicine, LTG-001. The oral therapy is designed to silence pain-signaling neurons by blocking a sodium channel called NaV 1.8.

Westlake had set out years ago to scout out new options for pain medicines, and found a research desert, according to founding managing director Sean Harper. But NaV 1.8 has emerged as a promising option because of its potential to be non-addictive and to lessen pain without affecting a person’s central nervous system, digestion, or heart rate, as opioids can. There were still few high-quality molecules in development that could be licensed from an academic lab or another drug company, so Westlake decided to develop its own.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article：调整装饰团花的样式，取消全息磁性开窗安全线。

WSS

The new shift in health care is toward less care

Excited delirium, Elijah McClain, and emergency physicians

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

Just how powerful is the placebo effect?

Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.

The new shift in health care is toward less care

focus

hotspot

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Rock icon Freddie Mercury pre

George Santos makes 1st court appearance after pleading not guilty to 13 counts

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

Apple is now the first public company to be valued at $3 trillion

Pediatricians' group reaffirms support for gender

Guidelines to prevent youth baseball injuries need more muscle

Does Medicare's free annual wellness visit do any good?

Heart attack and stroke risk calculators need revising

MoonLake credibility takes another hit with mid

Wikipedia

White House calls on federal agencies to crack down on AI abuses

Scientists find bacteria from stomach of ancient iceman

The Sacklers, horror, and ‘The Fall of the House of Usher’

Extreme heat events are a public health emergency

More doctors should go into startup world

Ambulance rides for just $100? Advisers want major billing fixes

knowledge

focus

explore

hotspot